Real-World data reveals how liraglutide affects teen obesity
NCT ID NCT07304141
First seen Jan 04, 2026 · Last updated Jun 20, 2026 · Updated 26 times
Summary
This study examined how the weight-loss drug liraglutide (Saxenda) affects body mass index and metabolic health in 128 adolescents aged 10-18 with obesity. Researchers collected real-world data from clinics in Sweden to see how the drug performs outside of controlled trials. The goal is to better understand the practical benefits and limitations of pharmacological treatment for childhood obesity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY (DISORDER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
the Regional Childhood Obesity Center, Queen Silvia's Children's Hospital.
Gothenburg, 416 50, Sweden
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Liraglutide (Saxenda)
What this could lead to
If successful, this could show how well liraglutide works in everyday care for teens with obesity, helping doctors make better treatment decisions.
What could go wrong
This is a small, retrospective study, not a controlled trial. Results may not apply to all teens, and the drug can cause side effects like nausea or vomiting.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.